Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vita Life Sciences Limited ( (AU:VLS) ) just unveiled an update.
Vita Life Sciences will buy back 658,502 unquoted shares issued under its employee Long Term Incentive Plan, following the satisfaction of performance hurdles attached to 875,000 plan shares granted in 2024 to six key executives, including Managing Director Mr. O’Keefe. The buy-back price is set at $2.5323 per share, based on the 10-day volume-weighted average on the ASX, and the repurchased shares will be cancelled with minimal impact on share capital and no effect on cash reserves.
Of the remaining 216,498 plan shares, 66,498 will convert to ordinary shares and be quoted on the ASX for five executives, while an executive holding 150,000 plan shares intends to repay the associated loan by 30 June 2026 so those shares can also become quoted ordinary shares. The move fine-tunes the company’s capital structure while fulfilling obligations under its incentive scheme, aligning executive interests with shareholders without straining liquidity.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the healthcare and life sciences sector, focusing on nutraceuticals and health products distributed primarily through retail and pharmacy channels in Australia and selected Asian markets. The company targets consumers seeking preventive health solutions and leverages long-term incentive plans to retain and reward key executives.
Average Trading Volume: 19,565
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$140.3M
Learn more about VLS stock on TipRanks’ Stock Analysis page.